Reported 6 days ago
Johnson & Johnson announced it will invest more than $2 billion to establish a new manufacturing facility in Wilson, North Carolina, which will enhance the production of biologic medicines aimed at treating cancer and other diseases. Set to begin construction in early 2025, the facility will create approximately 400 jobs and support J&J's goal of introducing over 70 new therapies by 2030.
Source: YAHOO